Akèy › Pèt tande
Etid klinik pou Pèt tande ap rekrite nan Etazini
56 etid pou Pèt tande ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY8 etid
- Los Angeles, CA5 etid
- Washington, DC5 etid
- Milwaukee, WI4 etid
- Boston, MA4 etid
- Baltimore, MD4 etid
- Cedar Rapids, IA3 etid
- San Francisco, CA3 etid
- Aurora, CO3 etid
- Durham, NC3 etid
- Rochester, MN3 etid
- Dallas, TX3 etid
Pa eta
- Arizona3 etid
- Colorado4 etid
- Florid5 etid
- Illinois3 etid
- Iowa3 etid
- Kalifòni12 etid
- Maryland8 etid
- Massachusetts4 etid
- Minnesota5 etid
- New York10 etid
- North Carolina4 etid
- Ohio3 etid
- Texas6 etid
- Wisconsin6 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT05730283Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Ap rekriteFaz 3
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT05821959Improving Spatial Perception and Speech Understanding in Multitalker Mixtures
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT05260307NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Ap rekriteEtid obsèvasyon
Laj 3 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT06303180Evaluation of Flexible Conductive Hearing Aids
Ap rekriteVolontè an sante akeyi
6 Months – 80 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07222202Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)
Ap rekriteEtid obsèvasyon
Laj 18 a 85 · Tout sèks · Mizajou Sep 9, 2026 · NCT04899037OTC Hearing Aid and MCI
Ap rekrite
Laj 60 a 90 · Tout sèks · Mizajou Sep 4, 2026 · NCT06112860Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 2, 2026 · NCT04915183Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
Ap rekrite
18 Months – 21 Years · Tout sèks · Mizajou Aug 28, 2026 · NCT02310399Open-label Study of SKY-GJB2 in Pediatric Subjects With GJB2-mediated Hearing Loss
Ap rekriteFaz 1/2
9 Months – 7 Years · Tout sèks · Mizajou Aug 27, 2026 · NCT07627971Listening Effort in Cochlear Implant Users
Ap rekriteVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Aug 25, 2026 · NCT06516575Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.
Ap rekriteEtid obsèvasyon
Laj 2 a 99 · Tout sèks · Mizajou Aug 18, 2026 · NCT05670496Early Age-Related Hearing Loss Investigation (EARHLI)
Ap rekrite
Laj 55 a 75 · Tout sèks · Mizajou Aug 12, 2026 · NCT06174038Use of Airpod Pros as Assistive Technology
Ap rekriteVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Aug 10, 2026 · NCT06840015A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
Ap rekriteFaz 1/2
Tout laj · Tout sèks · Mizajou Aug 5, 2026 · NCT05788536Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
Ap rekriteVolontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Jul 23, 2026 · NCT06729632Natural History of Autosomal Dominant Hearing Loss
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 3 a 99 · Tout sèks · Mizajou Jul 23, 2026 · NCT04501081Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06375278Evaluation of Clinical Outcomes of Ponto Procedures Performed in Settings Outside the Main Operating Room (i.e. Out-of-OR)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT06930781Neural Prediction to Enhance Language
Ap rekrite
0 Months – 5 Years · Tout sèks · Mizajou Jul 2, 2026 · NCT05962359Cochlear Implants in Young Children With SSD
Ap rekriteVolontè an sante akeyi
7 Months – 71 Months · Tout sèks · Mizajou Jun 26, 2026 · NCT05775367SPI-1005 in Adults Receiving Cochlear Implant
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06340633Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06663917Ph. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT07407582Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Ap rekrite
Laj 7 a 17 · Tout sèks · Mizajou Jun 15, 2026 · NCT05582551Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.